Mayne Pharma Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of MAYNF for the last semiannual is 127.94 M USD, and it's 133.07% higher compared to the previous semiannual. The net income of H1 24 is -48.03 M USD.